ArticleEBioMedicine2017

Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation.

Fernando Magro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.